Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Journal of Alzheimer'S Disease & Parkinsonism|May 16, 2022
Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-UpXianglin L Du, Lara M Simpson, Mikala C Osani, et al.
Stroke|December 25, 2010
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment studyRichard Sherva, Charles E Ford, John H Eckfeldt, et al.
American Journal of Hypertension|December 28, 2018
The Interaction of a Diabetes Gene Risk Score With 3 Different Antihypertensive Medications for Incident Glucose-level ElevationJoshua I Barzilay, Dejian Lai, Barry R Davis, et al.
JAMA Network Open|December 4, 2023
Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical TrialJose-Miguel Yamal, Journey Martinez, Mikala C Osani, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2019
Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT TrialStephen P Juraschek, Lara M Simpson, Barry R Davis, et al.
Current Opinion in Cardiology|June 4, 2010
ALLHAT: still providing correct answers after 7 yearsPaula T Einhorn, Barry R Davis, Jackson T Wright, et al.
Journal of the American Geriatrics Society|May 20, 2015
Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertensionPaula T Einhorn, Paul K Whelton, Barry R Davis, et al.
International Journal of Hypertension|November 30, 2013
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHATAmy I Lynch, Marguerite R Irvin, Barry R Davis, et al.
The American Journal of Cardiology|December 28, 2004
Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetesJohn B Kostis, Alan C Wilson, Ronald S Freudenberger, et al.
Stroke|March 1, 2008
Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly programAlpesh B Patel, John B Kostis, Alan C Wilson, et al.
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Journal of Alzheimer'S Disease & Parkinsonism|May 16, 2022
Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-UpXianglin L Du, Lara M Simpson, Mikala C Osani, et al.
Stroke|December 25, 2010
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment studyRichard Sherva, Charles E Ford, John H Eckfeldt, et al.
American Journal of Hypertension|December 28, 2018
The Interaction of a Diabetes Gene Risk Score With 3 Different Antihypertensive Medications for Incident Glucose-level ElevationJoshua I Barzilay, Dejian Lai, Barry R Davis, et al.
JAMA Network Open|December 4, 2023
Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical TrialJose-Miguel Yamal, Journey Martinez, Mikala C Osani, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2019
Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT TrialStephen P Juraschek, Lara M Simpson, Barry R Davis, et al.
Current Opinion in Cardiology|June 4, 2010
ALLHAT: still providing correct answers after 7 yearsPaula T Einhorn, Barry R Davis, Jackson T Wright, et al.
Journal of the American Geriatrics Society|May 20, 2015
Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertensionPaula T Einhorn, Paul K Whelton, Barry R Davis, et al.
International Journal of Hypertension|November 30, 2013
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHATAmy I Lynch, Marguerite R Irvin, Barry R Davis, et al.
The American Journal of Cardiology|December 28, 2004
Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetesJohn B Kostis, Alan C Wilson, Ronald S Freudenberger, et al.
Stroke|March 1, 2008
Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly programAlpesh B Patel, John B Kostis, Alan C Wilson, et al.
Pageof 19